These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 38791108)

  • 1. Metabolomics and Proteomics in Prostate Cancer Research: Overview, Analytical Techniques, Data Analysis, and Recent Clinical Applications.
    Al-Daffaie FM; Al-Mudhafar SF; Alhomsi A; Tarazi H; Almehdi AM; El-Huneidi W; Abu-Gharbieh E; Bustanji Y; Alqudah MAY; Abuhelwa AY; Guella A; Alzoubi KH; Semreen MH
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer-derived extracellular vesicles metabolic biomarkers: Emerging roles for diagnosis and prognosis.
    Hamed MA; Wasinger V; Wang Q; Graham P; Malouf D; Bucci J; Li Y
    J Control Release; 2024 Jul; 371():126-145. PubMed ID: 38768661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplexed quantitative proteomics in prostate cancer biomarker development.
    Gao Y; Kim H; Kitata RB; Lin TT; Swensen AC; Shi T; Liu T
    Adv Cancer Res; 2024; 161():31-69. PubMed ID: 39032952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer diagnosis and characterization with mass spectrometry imaging.
    Kurreck A; Vandergrift LA; Fuss TL; Habbel P; Agar NYR; Cheng LL
    Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):297-305. PubMed ID: 29209003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics in diagnosis of prostate cancer.
    Davalieva K; Polenakovic M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research.
    Ahmed M; Semreen AM; El-Huneidi W; Bustanji Y; Abu-Gharbieh E; Alqudah MAY; Alhusban A; Shara M; Abuhelwa AY; Soares NC; Semreen MH; Alzoubi KH
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive urine metabolomics of prostate cancer and its therapeutic approaches: a current scenario and future perspective.
    Kumar D; Nath K; Lal H; Gupta A
    Expert Rev Proteomics; 2021 Nov; 18(11):995-1008. PubMed ID: 34821179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omics sciences and precision medicine in prostate cancer.
    Medori MC; Micheletti C; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Calogero AE; Cannarella R; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):95-103. PubMed ID: 37994753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-platform 'multi-omic' profiling: unified mass spectrometry and computational workflows for integrative proteomics-metabolomics analysis.
    Blum BC; Mousavi F; Emili A
    Mol Omics; 2018 Oct; 14(5):307-319. PubMed ID: 30211418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical Metabolomics and Applications in Health, Environmental and Food Science.
    Fraga-Corral M; Carpena M; Garcia-Oliveira P; Pereira AG; Prieto MA; Simal-Gandara J
    Crit Rev Anal Chem; 2022; 52(4):712-734. PubMed ID: 33026841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging proteomics biomarkers and prostate cancer burden in Africa.
    Adeola HA; Blackburn JM; Rebbeck TR; Zerbini LF
    Oncotarget; 2017 Jun; 8(23):37991-38007. PubMed ID: 28388542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The applications of metabolomics in the molecular diagnostics of cancer.
    Cheung PK; Ma MH; Tse HF; Yeung KF; Tsang HF; Chu MKM; Kan CM; Cho WCS; Ng LBW; Chan LWC; Wong SCC
    Expert Rev Mol Diagn; 2019 Sep; 19(9):785-793. PubMed ID: 31414918
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced mass spectrometry-based multi-omics technologies for exploring the pathogenesis of hepatocellular carcinoma.
    Nie W; Yan L; Lee YH; Guha C; Kurland IJ; Lu H
    Mass Spectrom Rev; 2016; 35(3):331-49. PubMed ID: 24890331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of multiomic mass spectrometry approaches for the evaluation of human health following environmental exposure.
    Ferreira CR; Lima Gomes PCF; Robison KM; Cooper BR; Shannahan JH
    Mol Omics; 2024 Jun; 20(5):296-321. PubMed ID: 38623720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-omics approach.
    Soares NC; Ali A; Srinivasulu V; Sharaf BM; Giddey AD; Okendo J; Al-Hroub HM; Semreen MH; Hamad M; Al-Tel TH
    J Proteomics; 2022 Aug; 265():104660. PubMed ID: 35728772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging and the completion of the omics paradigm in breast cancer.
    Leithner D; Horvat JV; Ochoa-Albiztegui RE; Thakur S; Wengert G; Morris EA; Helbich TH; Pinker K
    Radiologe; 2018 Nov; 58(Suppl 1):7-13. PubMed ID: 29947931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of metabolomics to prostate cancer.
    Trock BJ
    Urol Oncol; 2011; 29(5):572-81. PubMed ID: 21930089
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.